Serum concentrations of CA 125, CA 15-3, CA 19-9 and CEA in normal pregnancy: A longitudinal study

Archives of Gynecology and Obstetrics

Volumn 285, Issue 3, 2012, Pages 579-584

  Ercan, Ŝerif ^a,b   Kaymaz, Özge ^a   Yücel, Nihal ^a   Orçun, Asuman ^a  

^a DR LUTFI KIRDAR KARTAL EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^b Cumhuriyet Mah Libadiye Cad Seçkin Sok Seçkinler Sitesi ^*  (Turkey)

Author keywords

CA 125, CA 15 3; CA 19 9; Carcinoembryonic antigen; Pregnancy; Tumor markers

Indexed keywords

CA 125 ANTIGEN; CA 15-3 ANTIGEN; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; TUMOR MARKER; MEMBRANE PROTEIN; MUC16 PROTEIN, HUMAN; MUCIN 1;

ADULT; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CHEMOLUMINESCENCE; FEMALE; FIRST TRIMESTER PREGNANCY; FOLLOW UP; GESTATION PERIOD; HUMAN; LONGITUDINAL STUDY; MATERNAL BLOOD; NORMAL HUMAN; NORMAL VALUE; PREGNANCY; PROSPECTIVE STUDY; SECOND TRIMESTER PREGNANCY; THIRD TRIMESTER PREGNANCY; ADOLESCENT; BLOOD;

ADOLESCENT; ADULT; CA-125 ANTIGEN; CA-19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; FEMALE; HUMANS; LONGITUDINAL STUDIES; MEMBRANE PROTEINS; MUCIN-1; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; PREGNANCY TRIMESTER, THIRD; PROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84861691205     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-011-2025-4     Document Type: Article

References (16)

1. Sarandakou A, Protonotariou E, Rizos D (2007) Tumor markers in biological fluids associated with pregnancy. Crit Rev Clin Lab Sci 44(2):151-178.
2. Schlageter MH, Larghero J, Cassinat B, Toubert ME, Borschneck C, Rain JD (1998) Serum Carcinoembryonic Antigen, Cancer Antigen 125, Cancer Antigen 15-3, Squamous Cell Carcinoma, and Tumor-associated Trypsin Inhibitor Concentrations during Healthy Pregnancy. Clin Chem 44(9):1995-1998.
3. Cheli CD, Morris DL, Neaman IE, Dai J, Allard WJ, Yeung KK (1999) Measurement of four tumor marker antigens in the sera of pregnant women. J Clin Lab Anal 13(1):35-39.
4. Keinan-Boker L, Lerner-Geva L, Kaufman B, Meirow D (2008) Pregnancy-Associated Breast Cancer. Isr Med Assoc J 10:722-727.
5. Pentheroudakis G (2008) Cancer and pregnancy. Ann Oncol. 19:38-39.
6. Høgdall E (2008) Cancer antigen 125 and prognosis. Curr Opin Obstet Gynecol 20:4-8.
7. Stu?rgeon C (2002) Practice guidelines for tumor marker use in the clinic. Clin Chem 48(8):1151-1159.
8. Duffy MJ (2006) Serum tumor markers in breast cancer: are they of clinical value? Clin Chem 52(3):345-351.
9. Fry LC, Mönkemüller K, Malfertheiner P (2008) Molecular markers of pancreatic cancer: development and clinical relevance. Langenbecks Arch Surg 393:883-890.
10. Goonetilleke KS, Siriwardena AK (2007) Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer. Eur J Surg Oncol 33(3):266-270.
11. Duffy MJ (2001) Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful? Clin Chem 47(4):624-630.
12. Touitou Y, Darbois Y, Bogdan A, Auzeby A, Keusseoglou S (1989) Tumour marker antigens during menses and pregnancy. Br J Cancer 60(3):419-420.
13. Bon GG, Kenemans P, Verstraeten AA, Go S, Philipi PA, van Kamp GJ, van Geijn HP, van Vugt JM (2001) Maternal serum Ca125 and Ca15-3 antigen levels in normal and pathological pregnancy. Fetal Diagn 16(3):166-172.
14. Kobayashi F, Sagawa N, Nakamura K, Nonogaki M, Ban C, Fujii S, Mori T (1989) Mechanism and clinical significance of elevated CA 125 levels in the sera of pregnant women. Am J Obstet Gynecol 160(3):563-566.
15. Spitzer M, Kaushal N, Benjamin F (1998) Maternal CA-125 levels in pregnancy and the puerperium. J Reprod Med 43(4):387-392.
16. Botsis D, Sarandakou A, Kassanos D, Kontoravdis A, Rizos D, Protonotariou E, Phocas I, Creatsas G (1999) Breast cancer markers during normal pregnancy. Anticancer Res 19(4C):3539-3541